These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21846900)

  • 1. A rare cause of late drug-eluting stent thrombosis unraveled by optical coherence tomography.
    Alfonso F; Gonzalo N; Hernández R
    Circ Cardiovasc Interv; 2011 Aug; 4(4):399-400. PubMed ID: 21846900
    [No Abstract]   [Full Text] [Related]  

  • 2. Late vascular responses from 2 to 4 years after implantation of sirolimus-eluting stents: serial observations by intracoronary optical coherence tomography.
    Takano M; Yamamoto M; Mizuno M; Murakami D; Inami T; Kimata N; Murai K; Kobayashi N; Okamatsu K; Ohba T; Seino Y; Mizuno K
    Circ Cardiovasc Interv; 2010 Oct; 3(5):476-83. PubMed ID: 20823394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very late stent thrombosis after sirolimus-eluting stent implantation observed using optical coherence tomography and coronary angioscopy.
    Ikenaga H; Dai K; Ishihara M
    J Invasive Cardiol; 2010 Nov; 22(11):557-8. PubMed ID: 21041855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very late thrombosis of sirolimus-eluting stent due to late malapposition: serial observations with optical coherence tomography.
    Sawada T; Shite J; Shinke T; Tanino Y; Ogasawara D; Kawamori H; Kato H; Miyoshi N; Yoshino N; Hirata K
    J Cardiol; 2008 Dec; 52(3):290-5. PubMed ID: 19027609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A; Cosgrave J; Latib A; Colombo A
    Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial.
    Guagliumi G; Costa MA; Sirbu V; Musumeci G; Bezerra HG; Suzuki N; Matiashvili A; Lortkipanidze N; Mihalcsik L; Trivisonno A; Valsecchi O; Mintz GS; Dressler O; Parise H; Maehara A; Cristea E; Lansky AJ; Mehran R; Stone GW
    Circulation; 2011 Jan; 123(3):274-81. PubMed ID: 21220730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean multicenter angioplasty team (KOMATE) Registry.
    Kim BK; Oh S; Jeon DW; Yang JY; Kim JS; Park S; Choi D; Jang Y; Hong BK; Kwon HM; Lee SW; Goh CW; Kwon K; Ryu SK;
    J Interv Cardiol; 2009 Oct; 22(5):411-9. PubMed ID: 19702679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy.
    Ayyanathan S; Hersh D; Coplan NL; Garratt K
    Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after unrestricted use of everolimus-eluting stent compared to paclitaxel- and sirolimus-eluting stents.
    Mahmoudi M; Delhaye C; Wakabayashi K; Ben-Dor I; Gonzalez MA; Maluenda G; Gaglia MA; Torguson R; Xue Z; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2011 Jun; 107(12):1757-62. PubMed ID: 21497782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Very late stent thrombosis after implantation of sirolimus eluting coronary stents].
    Xu L; Wang LF; Yang XC; Ge YG; Wang HS; Li WM; Ni ZH; Liu Y; Xia K; Cui L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):312-5. PubMed ID: 17711654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.
    Zellweger MJ; Kaiser C; Brunner-La Rocca HP; Buser PT; Osswald S; Weiss P; Mueller-Brand J; Pfisterer ME;
    J Nucl Med; 2008 Apr; 49(4):550-6. PubMed ID: 18344439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
    Garg P; Mauri L
    Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is increased platelet turnover responsible for low responsiveness to different thienopyridienes? A case report of recurrent stent thromboses.
    Freynhofer MK; Bruno V; Brozovic I; Grove EL; Kristensen SD; Willheim M; Hübl W; Huber K
    Thromb Haemost; 2011 Jul; 106(1):182-4. PubMed ID: 21544319
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrent episodes of very late stent thrombosis in a patient with aspirin hypersensitivity, stent fracture and malapposition.
    Barison A; de Carlo M; Bellini F; Capozza PF; Lunardini A; Petronio AS
    Acute Card Care; 2011 Mar; 13(1):52-4. PubMed ID: 21323408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.
    Zhang F; Qian J; Ge J
    J Invasive Cardiol; 2008 Aug; 20(8):423-5. PubMed ID: 18688068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Late stent thrombosis thirteen months after drug-eluting stent implantation].
    Sacha J; Wester A; Pluta W
    Kardiol Pol; 2008 Jan; 66(1):78-80; discussion 84-5. PubMed ID: 18266191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.
    Hannan EL; Wu C; Walford G; Culliford AT; Gold JP; Smith CR; Higgins RS; Carlson RE; Jones RH
    N Engl J Med; 2008 Jan; 358(4):331-41. PubMed ID: 18216353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical coherence tomography imaging of acute stent thrombosis after Stentys stent implantation.
    Timmers L; Belkacemi A; Agostoni P; Stella PR
    J Am Coll Cardiol; 2013 Apr; 61(17):e165. PubMed ID: 23500257
    [No Abstract]   [Full Text] [Related]  

  • 20. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.